Recently Updated Advisory Committee Materials
Recently Updated Advisory Committee Materials
-
-
Posted on April 12, 2012
Reproductive Health Drugs Advisory Committee
- Slides for the April 5, 2012 Meeting of the Reproductive Health Drugs Advisory Committee1
- Astellas Presentations for the April 5, 2012 Meeting of the Advisory Committee for Reproductive Health Drugs (PDF – 6.35MB)2 (PDF - 6.2MB)
- FDA Backup Presentations for the April 5, 2012 Meeting of the Advisory Committee for Reproductive Health Drugs (PDF – 133KB)3 (PDF - 196KB)
- FDA Main Presentations for the April 5, 2012 Meeting of the Advisory Committee for Reproductive Health Drugs (PDF – 1.17MB)4 (PDF - 808KB)
- Final Meeting Roster for the April 5, 2012 Meeting of the Reproductive Health Drugs Advisory Committee5 (PDF - 23KB)
- Final Questions for the April 5, 2012 Meeting of the Reproductive Health Drugs Advisory Committee6 (PDF - 12KB)
- Final Agenda for the April 5, 2012 Meeting of the Reproductive Health Drugs Advisory Committee7 (PDF - 20KB)
- 2012 Meeting Materials, Reproductive Health Drugs Advisory Committee8
Cardiovascular and Renal Drugs Advisory Committee
Advisory Committee Calendar
Oncologic Drugs Advisory Committee
Radiological Devices Panel
-
Posted on April 11, 2012
Anti-Infective Drugs Advisory Committee
- Slides for the April 4, 2012 Meeting of the Anti-Infective Drugs Advisory Committee14
- Janssen Presentations for the April 4, 2012 Meeting of the Anti-Infective Drugs Advisory Committee (PDF – 354KB)15 (PDF - 352KB)
- FDA Presentations for the April 4, 2012 Meeting of the Anti-Infective Drugs Advisory Committee (PDF – 269KB)16 (PDF - 132KB)
- Final Questions for the April 4, 2012 Meeting of the Anti-Infective Drugs Advisory Committee17 (PDF - 12KB)
- Final Meeting Roster for the April 4, 2012 Meeting of the Anti-Infective Drugs Advisory Committee18 (PDF - 19KB)
- 2012 Meeting Materials, Anti-Infective Drugs Advisory Committee19
- Final Agenda for the April 4, 2012 Meeting of the Anti-Infective Drugs Advisory Committee20 (PDF - 19KB)
No hay comentarios:
Publicar un comentario